Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration–time curve against a trough 15–20 μg/mL concentration

International Journal of Antimicrobial Agents - Tập 56 - Trang 106109 - 2020
Kazutaka Oda1,2, Hirofumi Jono1,3, Kisato Nosaka2, Hideyuki Saito1,3
1Department of Pharmacy, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan
2Department of Infection Control, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan
3Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan

Tài liệu tham khảo

Liu, 2011, Infectious Diseases Society of America. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children, Clin Infect Dis, 52, 10.1093/cid/cir034 McGuinness, 2017, Vancomycin resistance in Staphylococcus aureus, Yale J Biol Med, 90, 269 Filippone, 2017, The nephrotoxicity of vancomycin, Clin Pharmacol Ther, 102, 459, 10.1002/cpt.726 Matsumoto, 2013, Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring, J Infect Chemother, 19, 365, 10.1007/s10156-013-0599-4 Hiramatsu, 1997, Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin, Lancet, 350, 1670, 10.1016/S0140-6736(97)07324-8 Meng, 2019, Conversion from vancomycin trough concentration-guided dosing to area under the curve-guided dosing using two sample measurements in adults: implementation at an academic medical center, Pharmacotherapy, 39, 433, 10.1002/phar.2234 Neely, 2018, Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic vancomycin dosing, Antimicrob Agents Chemother, 62, 10.1128/AAC.02042-17 Finch, 2017, A quasi-experiment to study the impact of vancomycin area under the concentration–time curve-guided dosing on vancomycin-associated nephrotoxicity, Antimicrob Agents Chemother, 61, 10.1128/AAC.01293-17 Men, 2016, Association between the AUC0–24/MIC ratio of vancomycin and its clinical effectiveness: a systematic review and meta-analysis, PLoS One, 11, 10.1371/journal.pone.0146224 Clark, 2019, Examining the relationship between vancomycin area under the concentration time curve and serum trough levels in adults with presumed or documented staphylococcal infections, Ther Drug Monit, 41, 483, 10.1097/FTD.0000000000000622 van Hal, 2013, Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter, Antimicrob Agents Chemother, 57, 734, 10.1128/AAC.01568-12 Neely, 2014, Are vancomycin trough concentrations adequate for optimal dosing?, Antimicrob Agents Chemother, 58, 309, 10.1128/AAC.01653-13 Rybak, 2020, Am J Health Syst Pharm, 77, 835, 10.1093/ajhp/zxaa036 Aljefri, 2019, Vancomycin area under the curve and acute kidney injury: a meta-analysis, Clin Infect Dis, 69, 1881, 10.1093/cid/ciz051 Suzuki, 2012, Is peak concentration needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic–pharmacodynamic analysis in patients with methicillin-resistant Staphylococcus aureus pneumonia, Chemotherapy, 58, 308, 10.1159/000343162 Matzke, 1986, Clinical pharmacokinetics of vancomycin, Clin Pharmacokinet, 11, 257, 10.2165/00003088-198611040-00001 Yasuhara, 1998, Population pharmacokinetics of vancomycin in Japanese adult patients, Ther Drug Monit, 20, 139, 10.1097/00007691-199804000-00003 Rybak, 2009, Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists, Am J Health Syst Pharm, 66, 82, 10.2146/ajhp080434 Mehta, 2007, Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury, Crit Care, 11, R31, 10.1186/cc5713 Vincent, 1996, The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine, Intensive Care Med, 22, 707, 10.1007/BF01709751 Matsuo, 2009, Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan, Am J Kidney Dis, 53, 982, 10.1053/j.ajkd.2008.12.034 Levey, 2006, Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate, Ann Intern Med, 145, 247, 10.7326/0003-4819-145-4-200608150-00004 Chavada, 2017, Establishment of an AUC0–24 threshold for nephrotoxicity is a step towards individualized vancomycin dosing for methicillin-resistant Staphylococcus aureus bacteremia, Antimicrob Agents Chemother, 61, 10.1128/AAC.02535-16 Lodise, 2020, Antibacterial Resistance Leadership Group. The Emperor's New Clothes: prospective observational evaluation of the association between initial vancomycin exposure and failure rates among adult hospitalized patients with MRSA bloodstream infections (PROVIDE), Clin Infect Dis, 70, 1536, 10.1093/cid/ciz460 Casapao, 2015, Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis, Antimicrob Agents Chemother, 59, 2978, 10.1128/AAC.03970-14 Ungprasert, 2015, Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: a systematic review and meta-analysis of observational studies, Eur J Intern Med, 26, 285, 10.1016/j.ejim.2015.03.008 Chawla, 2014, Acute kidney injury and chronic kidney disease as interconnected syndromes, N Engl J Med, 371, 58, 10.1056/NEJMra1214243 Oda, 2019, Development and evaluation of a vancomycin dosing nomogram to achieve the target area under the concentration–time curve, A retrospective study. J Infect Chemother, 26, 444, 10.1016/j.jiac.2019.11.009 Carreno, 2017, Pilot study of a Bayesian approach to estimate vancomycin exposure in obese patients with limited pharmacokinetic sampling, Antimicrob Agents Chemother, 61, 10.1128/AAC.02478-16 Rosner, 2017, Acute kidney injury in patients with cancer, N Engl J Med, 376, 1770, 10.1056/NEJMra1613984